Any current/future new fundraising through debt or equity?

The company aims to remain a debt-free entity eventually but currently carries around INR 155 crores of debt. As a growing company with increasing volumes and value of sales, working capital requirements will continue. Capital expenditure (capex) for FY25 is expected to be in the range of INR 40 to 50 crores, primarily for capacity expansion focused on high-margin products. The company expects healthy cash flow generation from operations starting FY25, which will be used to fund capex and working capital. There is no specific mention of planned fundraising through equity. The intent is to meet

Any current/future capex/capital investment/strategic investment?

FY25 capex planned in the range of INR 40 to 50 crores annually, focusing on higher margin products. Completed sharp capex phase; upcoming capex to be more targeted toward premium grades and specific sectors requiring special pipes. Expansion aims to manufacture special grades of pipes currently imported to serve niche sectors with higher margins. New LSAW mill capex planned but specifics not fully finalized. Intent to keep investments aligned with growth in turnover and working capital needs, expecting internal accruals to fund capex and working capital. No immediate announcements on new expa

Future growth expectations in sales/revenue/volumes?

FY'24 growth guidance: 45% to 50% year-on-year, despite 54% growth already in 9 months; Q4 expected to be stronger. FY'25 growth outlook: Anticipated growth in the range of 30% to 40% over FY'24 due to better capacity utilization. Capacity expansion completed for seamless pipes with total 14,400 MT per annum by Q4 FY24; welded pipe capacity ramping up with utilization expected to reach 80%-85%. New client approvals in oil & gas, chemical, pharmaceutical, power, paint sectors support volume growth. Incremental volumes expected primarily from direct sales and exports, reducing dependence

Future growth expectations in earnings/operating earnings/profits/EPS?

FY'24 revenue growth guidance is 45% to 50% year-on-year; 54% growth seen in 9 months indicates potential for ~50% full-year growth. FY'25 expected growth is in the range of 30% to 40% from FY'24 levels due to higher capacity utilization. EBITDA margin for Q3 FY24 stood at 18.9%, up from 12.9% in Q3 FY23; margin improvement attributed to higher seamless pipe contribution and backward integration. PAT margin improved to 10.5% for 9 months FY24 from 8.2% in 9 months FY23; PAT doubled in Q3 FY24 compared to same quarter last year. Company targets gradual margin expansion, focusing on high

Current/ Expected Orderbook/ Pending Orders?

Current order book stands at approximately INR 230 crores. Approximately 20% of this order book is comprised of export orders. The company has been adding new clients across diverse industries such as oil & gas, pharmaceuticals, chemicals, engineering, paint, power, and railways. The mix of sectors contributing to orders has increased beyond traditional chemical sectors. The company is targeting continued incremental orders with capacity expansions supporting growth.

IN US

Sale is live|00:00:00left today

Venus Pipes & Tubes LtdQ4 FY25Industrial Products

Venus Pipes & Tubes Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,701P/E: 28.4Market Cap: ₹2.9K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 1

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 1

→FY'24 growth guidance: 45% to 50% year-on-year, despite 54% growth already in 9 months; Q4 expected to be stronger.
→FY'25 growth outlook: Anticipated growth in the range of 30% to 40% over FY'24 due to better capacity utilization.
→Capacity expansion completed for seamless pipes with total 14,400 MT per annum by Q4 FY24; welded pipe capacity ramping up with utilization expected to reach 80%-85%.
→New client approvals in oil & gas, chemical, pharmaceutical, power, paint sectors support volume growth.
→Incremental volumes expected primarily from direct sales and exports, reducing dependence on stockists/traders over next two quarters.
→Exports targeted to constitute at least 20% of total revenue with potential to increase as new markets (US, Middle East, Africa) develop.
→EBITDA and PAT have shown strong growth with further margin stability expected; healthy cash flows projected from FY25 onwards supporting growth.

Margin guidance

Category 3

→FY'24 revenue growth guidance is 45% to 50% year-on-year; 54% growth seen in 9 months indicates potential for ~50% full-year growth.
→FY'25 expected growth is in the range of 30% to 40% from FY'24 levels due to higher capacity utilization.
→EBITDA margin for Q3 FY24 stood at 18.9%, up from 12.9% in Q3 FY23; margin improvement attributed to higher seamless pipe contribution and backward integration.
→PAT margin improved to 10.5% for 9 months FY24 from 8.2% in 9 months FY23; PAT doubled in Q3 FY24 compared to same quarter last year.
→Company targets gradual margin expansion, focusing on higher margin products, especially with seamless pipe capacity ramp-up.
→Export share targeted to increase beyond 20% over medium term, contributing to higher margins.
→Operating cash flow expected to improve from FY25 due to moderation of capex and better working capital management.

3 more insights locked — sign up free to unlock

Fundraise plans

→The company aims to remain a debt-free entity eventually but currently carries around INR 155 crores of debt.
→As a growing company with increasing volumes and value of sales, working capital requirements will continue.
→Capital expenditure (capex) for FY25 is expected to be in the range of INR 40 to 50 crores, primarily for capacity expansion focused on high-margin products.
→The company expects healthy cash flow generation from operations starting FY25, which will be used to fund capex and working capital.
→There is no specific mention of planned fundraising through equity.
→The intent is to meet capex and working capital needs from internal accruals rather than external debt or equity issuance at this stage.

Order book

Yes

→Current order book stands at approximately INR 230 crores.
→Approximately 20% of this order book is comprised of export orders.
→The company has been adding new clients across diverse industries such as oil & gas, pharmaceuticals, chemicals, engineering, paint, power, and railways.
→The mix of sectors contributing to orders has increased beyond traditional chemical sectors.
→The company is targeting continued incremental orders with capacity expansions supporting growth.

Capex plans

Yes

→FY25 capex planned in the range of INR 40 to 50 crores annually, focusing on higher margin products.
→Completed sharp capex phase; upcoming capex to be more targeted toward premium grades and specific sectors requiring special pipes.
→Expansion aims to manufacture special grades of pipes currently imported to serve niche sectors with higher margins.
→New LSAW mill capex planned but specifics not fully finalized.
→Intent to keep investments aligned with growth in turnover and working capital needs, expecting internal accruals to fund capex and working capital.
→No immediate announcements on new expansions as work on plans is ongoing, with prioritization on margin accretive products.
→200 tons/month seamless capacity commissioned recently; full 400 tons/month capacity expected by Q4 FY24.
→Capacity expansion supports targeted double-digit growth in coming years.

How does Venus Pipes & Tubes Ltd rank vs peers in Industrial Products?

Pro feature

1Venus Pipes & Tubes Ltd

Rev 1Mar 3

See full Industrial Products sector rankings

Want more stocks like Venus Pipes & Tubes Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio